ICON (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider
of outsourced development services to the pharmaceutical,
biotechnology and medical device industries, today reported its
financial results for the third quarter ended September 30,
2011.
Net revenues for the quarter grew 7% to $241 million compared to
$225 million in the same quarter last year. Year-to-date, net
revenues were $703 million, representing a 5% increase over the
same period last year.
In Q3 US GAAP losses from operations were $3.6 million. During
the quarter the company undertook a number of cost reduction steps
which led to restructuring costs of $4.8 million. Before
restructuring charges operating income was $1.1 million or 0.5% of
revenue compared to $17.6 million or 7.8% of revenue for the same
period last year. The year to date income from operations before
restructuring charges was $32.6 million or 4.6% of revenue compared
to $70 million or 10.5% of revenue last year.
US GAAP net loss in the quarter was $2.7 million or 4c per
share. Excluding restructuring charges net income was $1.5 million
or 2 cents per share on a diluted basis, compared to $19.9 million
or 33 cents per share last year. Year to date net income before
restructuring charges was 27.4 million or 45c per share compared to
$65 million or $1.07 per share last year.
Days sales outstanding, comprising accounts receivable and
unbilled revenue less payments on account, were 52 days at
September 30, 2011, compared to 49 days at June 30 2011.
Net cash at September 30 2011 amounted to $166 million, compared
to net cash of $215 million at the end of June 2011. During the
quarter ICON acquired Firecrest Clinical Ltd for an initial cash
consideration of $24.4 million. Firecrest Clinical provides a
comprehensive site performance management system that is used to
improve compliance, consistency and execution of activities at
investigative sites.
The Board of Directors have approved a share buy-back programme
of up to $50 million to commence in Q4.
CEO Ciaran Murray commented, “Our success in developing
significant strategic partnerships has resulted in a milestone
quarter of record net new business of $431m. To position ourselves
for the future growth that will result from our backlog increasing
by 16% over last year we have added circa 500 staff during the
quarter which has impacted profitability. Looking forward, we will
continue to invest in both our existing business and in our
strategic relationships to provide quality services to our
customers. For 2012, we expect revenue growth to be in the region
of 15% to 20% and EPS to be in the range of $0.90 to $1.10.”
In addition to the financial measures prepared in accordance
with generally accepted accounting principles (GAAP), this press
release contains certain non-GAAP financial measures, including
non-GAAP operating and net income and non-GAAP diluted earnings per
share. While non-GAAP financial measures are not superior to or a
substitute for the comparable GAAP measures, ICON believes certain
non-GAAP information is useful to investors for historical
comparison purposes.
The company will hold its third quarter conference call today,
October 27, 2011 at 9:00 EST [14:00 Ireland & UK]. This call
and linked slide presentation can be accessed live from our website
at http://www.iconplc.com. A recording will also be available on
the website for 90 days following the call. In addition, a calendar
of company events, including upcoming conference presentations, is
available on our website, under “Investors”. This calendar will be
updated regularly.
The statements made in this press release may contain
forward-looking statements that involve a number of risks and
uncertainties. In addition to the matters described in this press
release, the ability to maintain large client contracts or enter
into new contracts, maintain client relationships and the ability
to manage the opening of new offices, the integration of new
business mergers and acquisitions, as well as other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the
actual results achieved by ICON. ICON disclaims any intent or
obligation to update these forward-looking statements.
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The Company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. With
headquarters in Dublin, Ireland, ICON currently, operates from 79
locations in 39 countries and has approximately 8,350 employees.
Further information is available at www.iconplc.com.
Source: ICON plc
ICON/ICLR-F
ICON plc
Consolidated Income Statements (Unaudited) (Before restructuring
charges) Three and Nine Months ended September 30,
2011 and September 30, 2010 (Dollars, in thousands, except
share and per share data) Three Months Ended
Nine Months Ended
September 30,
September30,
September 30,
September 30,
2011 2010 2011 2010 Gross
Revenue 335,332 323,230 958,575 945,868 Reimbursable
expenses 94,560 98,135 255,461 277,910
Net Revenue 240,772 225,095 703,114 667,958
Costs and expenses Direct costs 158,343 139,460
453,679 401,647 Selling, general and administrative 71,629 60,008
188,856 171,225 Depreciation and amortization 9,667 8,002 27,969
25,005
Total costs and
expenses 239,639 207,470 670,504 597,877
Income from
operations 1,133 17,625 32,610 70,081 Net interest
income /(expense) 131 276 303 145
Income before provision for income taxes 1,264
17,901 33,913 70,226 Provision for income taxes 202 1,998
(5,559) (5,255)
Net income 1,466 19,899 27,354 64,971
Net income per ordinary share Basic $0.02 $0.33 $0.45
$1.09 Diluted $0.02 $0.33 $0.45 $1.07
Weighted average number of ordinary shares Basic 60,471,985
59,940,045 60,381,814 59,576,777 Diluted 61,063,020
60,743,403 61,096,464 60,576,058
ICON plc Consolidated Income
Statements (Unaudited) (US GAAP) Three and Nine
Months ended September 30, 2011 and September 30, 2010
(Dollars, in thousands, except share and per share data)
Three Months Ended Six Months Ended
September 30,
September 30,
September 30,
September 30,
2011 2010 2011 2010 Gross
Revenue 335,332 323,230 958,575 945,868 Reimbursable
expenses 94,560 98,135 255,461 277,910
Net Revenue 240,772 225,095 703,114 667,958
Costs and expenses Direct costs 158,343 139,460
453,679 401,647 Selling, general and administrative 71,629 60,008
188,856 171,225 Depreciation and amortization 9,667 8,002 27,969
25,005 Restructuring Charges 4,815 - 9,817 -
Total
costs and expenses 244,454 207,470 680,321 597,877
(Loss)/Income from operations (3.682) 17,625 22,793 70,081
Net interest income /(expense) 131 276 303 145
(Loss) /Income before provision for
income taxes (3,551) 17,901 23,096 70,226 Provision for
income taxes 888 1,998 (4,329) (5,255)
Net income (2,663) 19,899 18,767
64,971 Net income per ordinary share Basic ($0.04)
$0.33 $0.31 $1.09 Diluted ($0.04) $0.33
$0.31 $1.07 Weighted average number of ordinary
shares Basic 60,471,985 59,940,045 60,381,814 59,576,777
Diluted 61,063,020 60,743,403 61,096,464 60,576,058
ICON plc Summary
Balance Sheet Data September 30, 2011 and
December 31, 2010 (Dollars, in thousands)
September 30, December 31, 2011 2010
(Unaudited) (Audited) Net cash 166,087
255,706 Accounts receivable 196,810 164,907 Unbilled revenue
133,211 101,431 Payments on account (137,460) (134,240) Total
192,561 132,098 Working Capital 277,078 329,350 Total
Assets 1,045,655 949,538 Shareholder's Equity 697,442
669,999
Source: ICON plc
Contact: Investor Relations 1-888-381-7923 or
Brendan Brennan CFO + 353 1 291 2000
Sam Farthing VP IR +353 1 291 2000
http://www.iconplc.com
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024